Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1353 of 6351
-
Smartwatch-Like device could help test DMD drugs in toddlers
Knowledge-focused Recruiting nowEvery year, 100 boys are born in the UK with a rare muscle disease called Duchenne muscular dystrophy. These boys cannot make an important muscle protein called dystrophin. They become weaker as they get older and lose the ability to walk as teenagers. This is a life-limiting con…
Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
New shot aims to keep blood pressure in check after hospital discharge
Disease control Recruiting nowThe purpose of this study is to evaluate the blood pressure-lowering effect of tonlamarsen in adult participants who were recently hospitalized and concurrently experienced an episode of acute severe hypertension.
Phase 2 • Sponsor: Kardigan, Inc. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New MRI method could spot oral cancer early in rare disease patients
Diagnosis Recruiting nowThis study being done to learn more about the use of medical Magnetic Resonance Imaging (mMRI) and dedicated dental MRI (ddMRI) as a non-invasive diagnosing tool when evaluating potential oral cancerous and precancerous lesions in Fanconi Anemia patients.
Sponsor: University of Minnesota • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC
-
New study explores immunotherapy for rare cancers in japanese patients
Disease control Recruiting nowResearchers are looking for new ways to treat people with solid tumors, lymphomas (blood cancers), and a certain type of skin cancer. The goals of this study are to learn: * About the safety of pembrolizumab (the study medicine) and if people tolerate it * What happens to differ…
Phase 1/2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New hope for Hard-to-Treat myeloma: early trial launches
Disease control Recruiting nowThis study will evaluate safety, pharmacokinetics (PK), clinical activity and pharmacodynamics (PD) of RO7851624 in participants with RRMM who are triple-class exposed (treated with proteasome inhibitors \[PIs\], immunomodulators \[IMiDs\], and anti-cluster of differentiation 38 …
Phase 1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Simple stretch test may spot pinched nerves without costly scans
Diagnosis Recruiting nowThis observational diagnostic accuracy study will evaluate the ability of the Slump Lateral Bending Test to identify patients with suspected peripheral neurogenic pain or neural mechanosensitivity. Adult participants will be assessed using clinical examination procedures, includi…
Sponsor: Fisiopoint Parma Physiotherapy • Aim: Diagnosis
Last updated Sep 05, 2026 00:00 UTC
-
Virtual reality may soothe teen anxiety during clinic visits
Symptom relief Not yet recruitingThis study examines the effectiveness of virtual reality (VR) protocols based on mindfulness as a nonpharmacological approach to reduce social anxiety among adolescents. Conducted as a non-randomized, controlled, multi-center trial, the research aims to provide evidence supportin…
Sponsor: Mohammed Bin Rashid University of Medicine and Health Sciences • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
New hope for kidney patients: drug aims to prevent relapse
Disease control Recruiting nowIgA nephropathy (IgAN) is a chronic progressive kidney disease, and long-term control of proteinuria and prevention of relapse are crucial for delaying disease progression. Patients with IgAN who achieve proteinuria remission after receiving Nefecon for 9 months or longer still f…
Phase 4 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Could a vaccine stop Alzheimer's before it starts? new trial begins
Vaccine Recruiting nowThis is a Phase 1, multicenter, randomized, double-blind, placebo-controlled, multiple-dose-escalation study evaluating the safety, tolerability, and immunogenicity of AV-1980R, an investigational vaccine targeting pathological tau, in participants with preclinical Alzheimer's di…
Phase 1 • Sponsor: Institute for Molecular Medicine • Aim: Vaccine
Last updated Aug 23, 2026 00:00 UTC
-
Flash of hope: millisecond radiation could spare healthy skin in cancer fight
Disease control Not yet recruitingThe goal of this clinical investigation is to describe and compare the toxicity and efficacy of an experimental radiotherapy, named FLASH therapy, to conventional radiotherapy for subjects suffering from localized Cutaneous Squamous Cell Carcinoma (cSCC) and Basal Cell Carcinoma …
Phase 2 • Sponsor: Jules Bordet Institute • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Promising drug combo targets Hard-to-Treat brain cancers
Disease control Recruiting nowThis phase I/II trial tests the safety, side effects best dose and effect of retifanlimab with or without difluoromethylornithine (DFMO) for the treatment of high grade gliomas that are growing, spreading, or getting worse (progressive). Immunotherapy with monoclonal antibodies, …
Phase 1/2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New drug combo aims to tackle Hard-to-Treat lymphoma
Disease control Recruiting nowThis study is to assess safety, tolerability, pharmacokinetics (PK), pharmacodynamic (PD), and preliminary efficacy of ARC-02.
Phase 1 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Sound waves to zap artery calcium before stenting: new trial launches
Disease control Recruiting nowProspective, Multi-center, Single-arm Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries prior to Trans-Carotid Stenting (SKYWARD Trans-Carotid IDE Study)
Sponsor: Shockwave Medical, Inc. • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
AI to predict heart damage from cancer treatments in major european study
Knowledge-focused Not yet recruitingCancer management has undergone major advances over the past 30 years. Several anticancer therapies are now highly effective, allowing many cancers to become chronic diseases through sequential lines of treatment. However, these therapies may be associated with severe cardiovascu…
Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
New surgical trick may stop spine from bending after major back surgery
Disease control Not yet recruitingPJK (proximal junctional kyphosis) at the upper end of spinal fusions after surgical correction of adult spinal deformity is not uncommon. Two-thirds of cases are observed within the first 3 months after surgery and 80% within the first 18 months. PJK is consequently a common pro…
Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for IIH headache sufferers: migraine drug tested in landmark trial
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if eptinezumab can reduce headache frequency and headache-related disability in adults with idiopathic intracranial hypertension (IIH) and chronic headache. It will also evaluate the safety and tolerability of eptinezumab in this patien…
Phase 3 • Sponsor: Rigmor Højland Jensen • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
New drug duo takes on advanced bladder cancer in early trial
Disease control Not yet recruitingThis is a Phase II clinical study aimed at evaluating the safety, tolerability, antitumor efficacy, PK and immunogenicity of AK146D1 monotherapy or combined with AK112 in advanced Urothelial carcinoma.
Phase 2 • Sponsor: Akeso • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Radioactive microspheres aim to shrink stubborn liver tumors
Disease control Not yet recruitingThis is a prospective, open-label, single-arm, investigator-initiated study designed to evaluate the safety and efficacy of NRT6003 Injection, a yttrium-90 carbon microsphere product, administered by selective internal radiation therapy in previously treated patients with hepatoc…
Phase 2 • Sponsor: Second Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a headset zap away insomnia? new trial aims to find out
Symptom relief Not yet recruitingA prospective, decentralized, individually-randomized, triple-blind\* sham-controlled, superiority trial to evaluate the safety and efficacy of HALO Clarity™ device in reducing insomnia severity. Participants will be randomized to Active and Sham device arms for four (4) weeks. …
Sponsor: Nexalin Technology • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
New pill could tame phenylketonuria by blocking amino acid absorption
Disease control Recruiting nowThis study is a Phase I single ascending dose clinical trial in which healthy adult volunteers were administered single oral doses of GenSci144 tablets at different levels. It was conducted using a randomized, double-blind, placebo-controlled design, primarily to evaluate the dru…
Phase 1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC